Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Complex roles for astrocytes in health and disease continue to emerge, highlighting this class of cells as integral to function and dysfunction of the nervous system. In particular, escalating evidence strongly implicates a range of changes in astrocyte structure and function associated with neuropsychiatric diseases including major depressive disorder, schizophrenia, and addiction. These changes can range from astrocytopathy, degeneration, and loss of function, to astrogliosis and hypertrophy, and can be either adaptive or maladaptive. Evidence from the literature indicates a myriad of changes observed in astrocytes from both human postmortem studies as well as preclinical animal models, including changes in expression of glial fibrillary protein, as well as changes in astrocyte morphology and astrocyte‐mediated regulation of synaptic function. In this review, we seek to provide a comprehensive assessment of these findings and consequently evidence for common themes regarding adaptations in astrocytes associated with neuropsychiatric disease. While results are mixed across conditions and models, general findings indicate decreased astrocyte cellular features and gene expression in depression, chronic stress and anxiety, but increased inflammation in schizophrenia. Changes also vary widely in response to different drugs of abuse, with evidence reflective of features of astrocytopathy to astrogliosis, varying across drug classes, route of administration and length of withdrawal. HighlightsAstrocytes perform many vital functions in the central nervous system.Both astrogliosis and astrocytopathy have been associated with CNS disorders.A decrease in GFAP and astrocyte morphology is associated with mood disorders.Increased GFAP expression is more associated with schizophrenic symptoms.Drugs of abuse induce broad changes in astrocyte gene expression and structure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 7×
“The most common way to identify astrocytes is GFAP expression; however, not all astrocytes express GFAP (Kimelberg, 2004; Kettenmann and Verkhratsky, 2011) and GFAP expression levels vary among brain region (Sofroniew and Vinters, 2010; Sofroniew, 2009).”
InfluentialZhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129 · cited 3×
“Most notably, fluorescence-activated cell sorting and isolation have revealed astrocyte enrichment in metabolic pathways, including an enrichment of enzymes related to glycolysis and the tricarboxylic acid/Krebs cycle [43, 44], which was functionally verified using ACCEPTED MANUSCRIPT”
Molecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594 · cited 4×
“The reactive astrogliosis response is a spectrum of changes, including both gain and loss of astrocytic function, that is dependent on the type and severity of the insult, and can result in either beneficial or detrimental effect on the surrounding neural tissue (for a review, see (Sofroniew, 2009)).”
InfluentialProtoplasmic Astrocytes in CA1 Stratum Radiatum Occupy Separate Anatomical Domains
Bushong, E. A., Martone, M. E., Jones, Y. Z., & Ellisman, M. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00183.2002 · Cited by 1,578
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · cited 1×
“Ceftriaxone, a β-lactam antibiotic that increases GLT-1 expression (Rothstein et al., 2005), has been shown to impair pre-pulse inhibition (PPI) of the acoustic startle reflex in rodents (Bellesi et al., 2009), a behavioral maladaptation often associated with schizophrenia.”
BackgroundRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 2×
“Initial reports indicated that the size of glial cells was increased in the DLPFC of MDD patients (Rajkowska et al., 1999), but other studies have reported no change in the overall glial cell size, as well as no change in the size of glial cell nuclei in the frontal cortex (Cotter et al., 2005,…”
BackgroundResultNew roles for astrocytes: redefining the functional architecture of the brain.
Nedergaard, M., Ransom, B., & Goldman, S. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.008 · Cited by 1,334
Magistretti, P. J., Pellerin, L., Rothman, D. L., & Shulman, R. G. (1999) · Science · doi:10.1126/science.283.5401.496 · Cited by 1,170
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020 · cited 1×
“For example, NMDAR antagonists such as phencyclidine (PCP) have been shown to induce positive symptoms of schizophrenia including psychosis (Olney et al., 1999), and others such as ketamine have been shown to induce negative symptoms (GunduzBruce, 2009).”
Emerging roles of astrocytes in neural circuit development
Clarke, L. E., & Barres, B. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3484 · Cited by 975 · cited 1×
“Astrocytes are named for their star-like appearance and serve many important functions, from providing energy and metabolic support to neurons, to roles in synaptic development and signaling, glutamate uptake and release, regulation of blood flow, and neuroprotection (for review, see (Sofroniew and Vinters, 2010; Nede…”
Glia — more than just brain glue
Allen, N. J., & Barres, B. A. (2009) · Nature · doi:10.1038/457675a · Cited by 856
Synaptic Islands Defined by the Territory of a Single Astrocyte
Halassa, M. M., Fellin, T., Takano, H., Dong, J.-H., & Haydon, P. G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1419-07.2007 · Cited by 767
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702 · cited 1×
“A decrease in glutamatergic signaling as a result of impaired NMDA receptor (NMDAR) function has been widely hypothesized as an important contributing cellular mechanism for schizophrenia (Hardingham and Do, 2016; Catts et al., 2016; Howes et al., 2015; Balu and Coyle, 2015).”
BackgroundHan, X., Chen, M., Wang, F., Windrem, M., Wang, S., Shanz, S., Xu, Q., Oberheim, N. A., Bekar, L., Betstadt, S., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.015 · Cited by 635
Cotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634 · cited 1×
“Initial reports indicated that the size of glial cells was increased in the DLPFC of MDD patients [90], but other studies have reported no change in the overall glial cell size, as well as no change in the size of glial cell nuclei in the frontal cortex [91, 92].”
Functional diversity of astrocytes in neural circuit regulation
Haim, L. B., & Rowitch, D. H. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.159 · Cited by 618
Astrocyte-derived ATP modulates depressive-like behaviors
Cao, X., Li, L.-P., Wang, Q., Wu, Q., Hu, H.-H., Zhang, M., Fang, Y.-Y., Zhang, J., Li, S.-J., Xiong, W.-C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3162 · Cited by 615
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603 · cited 1×
“dementia, stress, major depressive disorders, schizophrenia and substance use disorders (Niciu et al., 2014; Bedner et al., 2015; Scofield et al., 2016; Braun et al., 2009; Czeh et al., 2005; Rajkowska and Stockmeier, 2013); for a review see (Verkhratsky et al.”
Rajkowska, G., Selemon, L. D., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.215 · Cited by 537 · cited 5×
“Effects on astrocyte marker Study design Brain region Reference No change in GFAP; but younger MDD patients show decreased GFAP MDD patients DLPFC Miguel-Hidalgo et al., 2000 No change in GFAP MDD patients Entorhinal cortex Damadzic et al., 2001 No difference in GFAP Wistar-Kyoto rat model of depression Insular cortex…”
InfluentialConradi, H. J., Ormel, J., & de Jonge, P. (2011) · Psychological Medicine · doi:10.1017/s0033291710001911 · Cited by 515
Han, J., Kesner, P., Metna-Laurent, M., Duan, T., Xu, L., Georges, F., Koehl, M., Abrous, D. N., Mendizabal-Zubiaga, J., Grandes, P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.037 · Cited by 514
Lactate promotes plasticity gene expression by potentiating NMDA signaling in neurons
Yang, J., Ruchti, E., Petit, J.-M., Jourdain, P., Grenningloh, G., Allaman, I., & Magistretti, P. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322912111 · Cited by 504
Banasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458
Elusive roles for reactive astrocytes in neurodegenerative diseases
Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453 · cited 1×
“Findings from preclinical studies examining changes in GFAP expression after alcohol exposure have predominantly shown an increase in GFAP expression, suggesting astrogliosis and an increased inflammatory response after alcohol drinking [296].”
The involvement of glial cells in the development of morphine tolerance
Song, P., & Zhao, Z.-Q. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(00)00226-1 · Cited by 445
Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434 · cited 3×
“Moreover, chronic psychosocial stress has been reported to decrease GFAP expression in the hippocampus of male tree shrews [57].”
Astrocyte intermediate filaments in CNS pathologies and regeneration
Pekny, M., & Pekna, M. (2004) · The Journal of Pathology · doi:10.1002/path.1645 · Cited by 420 · cited 3×
“Astrocytes are classified based on morphology and astrocyte-specific biomarkers such as glial-fibrillary acid protein (GFAP), the glutamate transporter GLT-1, Ca+ binding protein S100β, glutamine synthetase (GS), connexin, the aquaporin receptor (AQP4) (Pekny and Pekna, 2004; Rouach et al., 2002; Gonçalves et al., 200…”
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
Trépanier, M. O., Hopperton, K. E., Mizrahi, R., Mechawar, N., & Bazinet, R. P. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.90 · Cited by 360
Pekny, M., Levéen, P., Pekna, M., Eliasson, C., Berthold, C. H., Westermark, B., & Betsholtz, C. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07147.x · Cited by 336 · cited 1×
“In fact, genetic deletion of GFAP in mice leads to a remarkably normal phenotype [87, 88] .”
Astrocyte uncoupling as a cause of human temporal lobe epilepsy
Bedner, P., Dupper, A., Hüttmann, K., Müller, J., Herde, M. K., Dublin, P., Deshpande, T., Schramm, J., Häussler, U., Haas, C. A., et al. (2015) · Brain · doi:10.1093/brain/awv067 · Cited by 328
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Lacagnina, M. J., Rivera, P. D., & Bilbo, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.121 · Cited by 271 · cited 1×
“gagement of astrocytes in the development of substance use disorders has emerged in recent years (Scofield and Kalivas, 2014; Lacagnina et al., 2017).”
Cobb, J. A., O’Neill, K., Milner, J., Mahajan, G. J., Lawrence, T. J., May, W. L., Miguel-Hidalgo, J., Rajkowska, G., & Stockmeier, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.044 · Cited by 254
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity
Miguel-Hidalgo, J. J., Waltzer, R., Whittom, A. A., Austin, M. C., Rajkowska, G., & Stockmeier, C. A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.003 · Cited by 218 · cited 2×
“For example, immunohistochemistry studies examining EAAT2 protein expression in MDD patients have shown a decrease in EAAT2 expression in the orbitofrontal cortex [62].”
The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
Balu, D. T., & Coyle, J. T. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.004 · Cited by 208 · cited 2×
“A decrease in glutamatergic signaling as a result of impaired NMDA receptor (NMDAR) function has been widely hypothesized as an important contributing cellular mechanism for schizophrenia (Hardingham and Do, 2016; Catts et al., 2016; Howes et al., 2015; Balu and Coyle, 2015).”
Tynan, R. J., Beynon, S. B., Hinwood, M., Johnson, S. J., Nilsson, M., Woods, J. J., & Walker, F. R. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1102-0 · Cited by 199
Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking
Scofield, M. D., Boger, H. A., Smith, R. J., Li, H., Haydon, P. G., & Kalivas, P. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.016 · Cited by 197
Webster, M. J., Knable, M. B., Johnston-Wilson, N., Nagata, K., Inagaki, M., & Yolken, R. H. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0646 · Cited by 179 · cited 2×
“Although some studies have reported no change in GFAP expression in the entorhinal cortex [184] and PFC [60], one study has shown an increase in GFAP in the DLPFC in patients diagnosed with bipolar disorder [185].”
Zink, M., Vollmayr, B., Gebicke-Haerter, P. J., & Henn, F. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.09.005 · Cited by 177 · cited 1×
“For example, GLT-1 mRNA levels are decreased in the hippocampus following learned helplessness in rats [111].”
Matos, M., Shen, H.-Y., Augusto, E., Wang, Y., Wei, C. J., Wang, Y. T., Agostinho, P., Boison, D., Cunha, R. A., & Chen, J.-F. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.026 · Cited by 153 · cited 4×
“Interestingly, these mice also exhibit deficits in GLT-1 activity, indicating a common link between astrocyte derived adenosine and glutamate uptake (Matos et al., 2015).”
BackgroundInfluentialClinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression
Trivedi, M. H., Hollander, E., Nutt, D., & Blier, P. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0211 · Cited by 153
Torres-Platas, S. G., Nagy, C., Wakid, M., Turecki, G., & Mechawar, N. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.65 · Cited by 148
Bull, C., Freitas, K. C., Zou, S., Poland, R. S., Syed, W. A., Urban, D. J., Minter, S. C., Shelton, K. L., Hauser, K. F., Negus, S. S., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.135 · Cited by 145 · cited 2×
“A similar inhibitory effect of astroglial Gq-DREADD stimulation has been observed on alcohol selfadministration [233].”
Restraint stress-induced morphological changes at the blood-brain barrier in adult rats
Sántha, P., Veszelka, S., Hoyk, Z., Mészáros, M., Walter, F. R., Tóth, A. E., Kiss, L., Kincses, A., Oláh, Z., Seprényi, G., et al. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00088 · Cited by 136 · cited 1×
“Chronic restraint stress has been shown to decrease GFAP in the hippocampus and frontal cortex [79, 80], the rostral ventromedial medulla [81] and ACCEPTED MANUSCRIPT”
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Lener, M. S., Kadriu, B., & Zarate, C. A. (2017) · Drugs · doi:10.1007/s40265-017-0702-8 · Cited by 131 · cited 1×
“Evidence for the role of NMDA receptors in mood disorders is shown by treatment with sub-anesthetic doses of the NMDA receptor antagonist ketamine, which elicits rapid anti-depressive behaviors in both patients with MDD (reviewed in (Lener et al., 2017; Schwartz et al., 2016)), and animal models (Shirayama and Hashimo…”
Matute, C., Melone, M., Vallejo‐Illarramendi, A., & Conti, F. (2005) · Glia · doi:10.1002/glia.20119 · Cited by 129
D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase
Ehmsen, J. T., Ma, T. M., Sason, H., Rosenberg, D., Ogo, T., Furuya, S., Snyder, S. H., & Wolosker, H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4914-12.2013 · Cited by 118
Inhibition of Lactate Transport Erases Drug Memory and Prevents Drug Relapse
Zhang, Y., Xue, Y., Meng, S., Luo, Y., Liang, J., Li, J., Ai, S., Sun, C., Shen, H., Zhu, W., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.007 · Cited by 106
Zhao, J., Verwer, R. W. H., van Wamelen, D. J., Qi, X.-R., Gao, S.-F., Lucassen, P. J., & Swaab, D. F. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.06.017 · Cited by 83 · cited 1×
“Another study has shown that in addition to EAAT2, EAAT1 is also downregulated in DLPFC of MDD patients who committed suicide [101].”
Curcio, L., Podda, M. V., Leone, L., Piacentini, R., Mastrodonato, A., Cappelletti, P., Sacchi, S., Pollegioni, L., Grassi, C., & D’Ascenzo, M. (2013) · Brain · doi:10.1093/brain/awt036 · Cited by 79
D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in Rats
Seif, T., Simms, J. A., Lei, K., Wegner, S., Bonci, A., Messing, R. O., & Hopf, F. W. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.84 · Cited by 75 · cited 1×
“Modulation of synaptic function The role NMDA receptors in alcohol intake has been demonstrated by studies showing that systemic treatment of the NMDA receptor co-agonist D-serine and D-cycloserine can reduce aversion resistant alcohol intake [323].”
The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats
Hao, S., Liu, S., Zheng, X., Zheng, W., Ouyang, H., Mata, M., & Fink, D. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.197 · Cited by 74 · cited 1×
“Supporting these findings, morphine withdrawal increases GFAP expression in the periaqueductal gray, suggesting astrocyte activation correlates with the release of TNFα (Hao et al., 2011).”
BackgroundStrategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms
Kurian, B. T., Greer, T. L., & Trivedi, M. H. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.53 · Cited by 73 · cited 1×
“sleeping, lack of energy, anxiety, anhedonia, impaired cognition and pain (Kurian et al., 2009; Trivedi et al., 2008; Blier and Briley, 2011; Conradi et al., 2011).”
Zamberletti, E., Gabaglio, M., Grilli, M., Prini, P., Catanese, A., Pittaluga, A., Marchi, M., Rubino, T., & Parolaro, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.008 · Cited by 73
Sex and Adolescent Ethanol Exposure Influence Pavlovian Conditioned Approach
Madayag, A. C., Stringfield, S. J., Reissner, K. J., Boettiger, C. A., & Robinson, D. L. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13354 · Cited by 50
Self-citationKarlsson, R.-M., Adermark, L., Molander, A., Perreau-Lenz, S., Singley, E., Solomon, M., Holmes, A., Tanaka, K., Lovinger, D. M., Spanagel, R., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.027 · Cited by 44 · cited 1×
“Moreover, GLAST knockout mice do not exhibit a place preference for ethanol but do show reduced ethanol intake compared to wild-type mice, [322]; accordingly, the role of GLAST expression in alcohol intake is not straightforward.”
Chen, J.-X., Yao, L.-H., Xu, B.-B., Qian, K., Wang, H.-L., Liu, Z.-C., Wang, X.-P., & Wang, G.-H. (2014) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-014-1362-5 · Cited by 39
Cited by
Astrocyte-neuron metabolic cooperation shapes brain activity
Bonvento, G., & Bolaños, J. P. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.006 · Cited by 580
The S100B story: from biomarker to active factor in neural injury
Michetti, F., D'Ambrosi, N., Toesca, A., Puglisi, M. A., Serrano, A., Marchese, E., Corvino, V., & Geloso, M. C. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14574 · Cited by 410
Morphological, cellular and molecular basis of brain infection in COVID-19 patients
Crunfli, F., Carregari, V. C., Veras, F. P., Vendramini, P. H., Valença, A. G. F., Antunes, A. S. L. M., Brandão-Teles, C., da Silva Zuccoli, G., Reis-de-Oliveira, G., Silva-Costa, L. C., et al. (2020) · doi:10.1101/2020.10.09.20207464 · Cited by 331
TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward
Guilarte, T. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.003 · Cited by 173
Gupta, A. K., Gupta, S., Mehan, S., Khan, Z., Das Gupta, G., & Narula, A. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05001-5 · Cited by 59
Metadata
- Authors
- Kim, R., Healey, K. L., Sepulveda-Orengo, M. T., & Reissner, K. J.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 87
- Issue
- Pt A
- Pages
- 126-146
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2763706037
- Cited by
- 141
- References
- 60
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.